Article (Scientific journals)
Reproducibility of PD patient-specific midbrain organoid data for in vitro disease modeling.
ZUCCOLI, Elisa; Al Sawaf, Haya; Tuzza, Mona et al.
2025In iScience, 28 (10), p. 113541
Peer Reviewed verified by ORBi
 

Files


Full Text
1-s2.0-S2589004225018024-main.pdf
Publisher postprint (8.78 MB) Creative Commons License - Attribution
Download

All documents in ORBilu are protected by a user license.

Send to



Details



Keywords :
Neuroscience; cell biology; molecular biology; omics; Multidisciplinary
Abstract :
[en] Midbrain organoids are advanced in vitro cellular models for disease modeling. They have been used successfully over the past decade for Parkinson's disease (PD) research and drug development. The three-dimensional structure and multicellular composition allow disease research under more physiological conditions than is possible with conventional 2D cellular models. However, there are concerns in the field regarding the organoid batch-to-batch variability and thus the reproducibility of the results. In this manuscript, we generate multiple independent midbrain organoid batches derived from healthy individuals or glucocerebrosidase (GBA)-N370S mutation-carrying PD patients to evaluate the reproducibility of the GBA-N370S mutation-associated PD transcriptomic and metabolic signature as well as selected protein abundance. Our analysis shows that GBA-PD-associated phenotypes are reproducible across organoid generation batches and time points. This proves that midbrain organoids are not only suitable for PD in vitro modeling but also represent robust and highly reproducible cellular models.
Disciplines :
Life sciences: Multidisciplinary, general & others
Author, co-author :
ZUCCOLI, Elisa  ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Developmental and Cellular Biology
Al Sawaf, Haya;  Developmental and Cellular Biology, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, 6, Avenue du Swing, 4367 Belvaux, Luxembourg
Tuzza, Mona;  Developmental and Cellular Biology, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, 6, Avenue du Swing, 4367 Belvaux, Luxembourg
Nickels, Sarah L;  Developmental and Cellular Biology, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, 6, Avenue du Swing, 4367 Belvaux, Luxembourg
ZAGARE, Alise ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine > Developmental and Cellular Biology > Team Jens Christian SCHWAMBORN
SCHWAMBORN, Jens Christian  ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Developmental and Cellular Biology
External co-authors :
yes
Language :
English
Title :
Reproducibility of PD patient-specific midbrain organoid data for in vitro disease modeling.
Publication date :
17 October 2025
Journal title :
iScience
eISSN :
2589-0042
Publisher :
Elsevier Inc., United States
Volume :
28
Issue :
10
Pages :
113541
Peer reviewed :
Peer Reviewed verified by ORBi
FnR Project :
FNR/NCER13/BM/11264123
PRIDE19/14254520
CORE 22_BM_17193204_MidStriPD
Funders :
Fonds National de la Recherche Luxembourg
Fonds National de la Recherche Luxembourg
Fonds National de la Recherche Luxembourg
Funding text :
The work with iPSCs has been approved by the Ethics Review Panel (ERP) of the University of Luxembourg and the national Luxembourgish Research Ethics Committee (CNER, Comit\u00E9 National d'Ethique de Recherche) under CNER No. 201901/01 (ivPD) and No. 202406/03 (AdvanceOrg).This project has received funding from the National Centre of Excellence in Research on Parkinson's Disease (NCER-PD), which is funded by the Luxembourg National Research Fund (FNR) (FNR/NCER13/BM/11264123). Further, FNR funding as part of the i2TRON Doctoral Training Unit (PRIDE19/14254520) and the CORE program (CORE 22_BM_17193204_MidStriPD) is acknowledged.This research was funded in whole by the FNR Luxembourg. For the purpose of Open Access, the author has applied a CC BY public copyright license to any Author Accepted Manuscript (AAM) version arising from this submission.This project has received funding from the National Centre of Excellence in Research on Parkinson\u2019s Disease (NCER-PD), which is funded by the Luxembourg National Research Fund ( FNR ) ( FNR/NCER13/BM/11264123 ). Further, FNR funding as part of the i2TRON Doctoral Training Unit ( PRIDE19/14254520 ) and the CORE program ( CORE 22_BM_17193204_MidStriPD ) is acknowledged.
Available on ORBilu :
since 29 January 2026

Statistics


Number of views
7 (0 by Unilu)
Number of downloads
2 (0 by Unilu)

Scopus citations®
 
0
Scopus citations®
without self-citations
0
OpenCitations
 
0
OpenAlex citations
 
0
WoS citations
 
0

Bibliography


Similar publications



Contact ORBilu